Carcinoid tumours are relatively uncommon, accounting for only 1-6% of all lung tumours.' At one time they were regarded as benign but they are now recognised as tumours of low grade malignant potential, forming part of a histological spectrum ranging from typical carcinoids to small cell neuroendocrine carcinomas.2 They have a more favourable prognosis than other malignant lung tumours, but their behaviour may be difficult to predict from the histological pattern. Factors that have been associated with a worse prognosis in bronchial carcinoid tumours are increasing age, higher T stage or N stage, mitotic count, necrosis, nuclear pleomorphism, vascular and lymphatic invasion, and an undifferentiated growth pattern. 3 Cytogenetic changes are a recognised feature of many human tumours and may be related to clinical behaviour. 4 The number of chromosomes may be either increased (hyperdiploid) or, less frequently, decreased (hypodiploid), and structurally abnormal "marker" chromosomes may appear. Quantitative changes in chromosome content can be estimated indirectly by measuring cellular DNA content by static or flow cytometry.56 Two groups of tumours are distinguished: those with a normal or near normal, diploid DNA content, and those with an abnormal, aneuploid DNA content. The measurement ofcellular DNA content has been increasingly facilitated by flow cytometry, and techniques are now sufficiently refined to be clinically useful. Methods for the analysis of paraffin embedded tissue7 have allowed material from uncommon tumours such as bronchial carcinoids to be reexamined.
The aim of the present study was to determine whether the measurement of tumour DNA content by flow cytometry could enhance the pathological assessment and help to predict the prognosis of bronchopulmonary carcinoid tumours.
Methods
The study group consisted of 53 patients presenting with bronchopulmonary carcinoid tumours to the North West Regional Cardiothoracic Centre (Wythenshawe Hospital) 0 6 (fig 1) . In both hypodiploid cases there were two GO/G1 peaks, but the second peaks were in the channel range for normal diploid peaks (about channel 50). The presence of a DNA hypodiploid population was confirmed by repeating the analysis of the samples and including normal lung tissue from a different block from the same specimen. This enriched the second GO/G 1 peak, indicating that the first peak in a low channel number represented a hypodiploid population (fig 2) .
Nine of the 28 typical carcinoids were DNA aneuploid, compared with 17 of the 25 well differentiated neuroendocrine carcinomas (X2 = 5-44, p < 0-02). DNA aneuploidy was present in a significantly higher proportion of undifferentiated tumours (15 (fig 3) . This difference was at the borderline of significance (p = 0-052). In a Cox multivariate regression analysis, the most powerful predictor of prognosis was the histological growth pattern. The only other variables of independent prognostic significance were the presence of affected lymph nodes and the presence of nuclear pleomorphism. Determination ofDNA ploidy did not confer independent prognostic information. The duration ofsurvival ofthose with DNA aneuploid tumours was independent of the DNA index and the size of the aneuploid peak.
Discussion
The measurement of cellular DNA content by flow cytometry is emerging as a potential aid to the pathological assessment of various human tumours. In the present study DNA aneuploidy was detected both in typical bronchopulmonary carcinoid tumours and in well differentiated neuroendocrine carcinomas, although the incidence in the latter was significantly higher. Blondal et al8 studied The biological relevance of DNA aneuploidy to malignant transformation and progression is uncertain. In the present study DNA aneuploidy was not a prerequisite for malignant behaviour and did not invariably confer features of increased malignant potential. It has also been detected in premalignant dysplastic lesions in chronic ulcerative colitis,22 23 Barrett's oesophagus,24 and benign colorectal polyps. 25 Jones, Hasleton, Moore
The generation of an aneuploid population is probably an epiphenomenon, reflecting increased genetic instability associated with malignant transformation. If chromosomal rearrangements are implicated in the pathogenesis of neoplasia, they are presumably subchromosomal or limited to specific genes. Measurement of cellular DNA content by flow cytometry is not sufficiently sensitive to detect such changes.
In conclusion, DNA aneuploidy is an indicator of increased malignant potential in bronchopulmonary carcinoid tumours. The determination of DNA ploidy by flow cytometry, however, is of limited clinical value by comparison with conventional pathological assessment.
